New Report Highlights Increased Importance of Risk Reduction in Chronic Obstructive Pulmonary Disease (COPD) Management
New Expert Report on COPD Launched at a Press Conference at ERS 2012 2 September…
New data analysis supports the use of Daxas
Data presented at ERS 2011 supports the use of Daxas® (roflumilast) to further stabilize patients experiencing frequent COPD exacerbations
New partnership with Global Angels to be launched at ERS
Nycomed partners with charity to improve provision of primary healthcare for people in need
Data to be presented at ERS 2011
Data reinforcing the benefit of Daxas® (roflumilast) as a treatment to target COPD inflammation will be presented at ERS 2011
The information contained in this site is for medical journalists only. Click "OK" if you are a medical journalist.